Table of Content

1 Burosumab Market Overview
1.1 Product Overview and Scope of Burosumab
1.2 Burosumab Segment by Type
1.2.1 Global Burosumab Market Value Comparison by Type (2024-2034)
1.2.2 10mg/mL
1.2.3 20mg/mL
1.2.4 30mg/mL
1.3 Burosumab Segment by Application
1.3.1 Global Burosumab Market Value by Application: (2024-2034)
1.3.2 Minor Patients Over 1 Year Old
1.3.3 Adult Patients
1.4 Global Burosumab Market Size Estimates and Forecasts
1.4.1 Global Burosumab Revenue 2024-2034
1.4.2 Global Burosumab Sales 2024-2034
1.4.3 Global Burosumab Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Burosumab Market Competition by Manufacturers
2.1 Global Burosumab Sales Market Share by Manufacturers (2024-2024)
2.2 Global Burosumab Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Burosumab Average Price by Manufacturers (2024-2024)
2.4 Global Burosumab Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Burosumab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Burosumab, Product Type & Application
2.7 Burosumab Market Competitive Situation and Trends
2.7.1 Burosumab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Burosumab Players Market Share by Revenue
2.7.3 Global Burosumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Burosumab Retrospective Market Scenario by Region
3.1 Global Burosumab Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Burosumab Global Burosumab Sales by Region: 2024-2034
3.2.1 Global Burosumab Sales by Region: 2024-2024
3.2.2 Global Burosumab Sales by Region: 2024-2034
3.3 Global Burosumab Global Burosumab Revenue by Region: 2024-2034
3.3.1 Global Burosumab Revenue by Region: 2024-2024
3.3.2 Global Burosumab Revenue by Region: 2024-2034
3.4 North America Burosumab Market Facts & Figures by Country
3.4.1 North America Burosumab Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Burosumab Sales by Country (2024-2034)
3.4.3 North America Burosumab Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Burosumab Market Facts & Figures by Country
3.5.1 Europe Burosumab Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Burosumab Sales by Country (2024-2034)
3.5.3 Europe Burosumab Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Burosumab Market Facts & Figures by Country
3.6.1 Asia Pacific Burosumab Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Burosumab Sales by Country (2024-2034)
3.6.3 Asia Pacific Burosumab Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Burosumab Market Facts & Figures by Country
3.7.1 Latin America Burosumab Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Burosumab Sales by Country (2024-2034)
3.7.3 Latin America Burosumab Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Burosumab Market Facts & Figures by Country
3.8.1 Middle East and Africa Burosumab Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Burosumab Sales by Country (2024-2034)
3.8.3 Middle East and Africa Burosumab Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Burosumab Sales by Type (2024-2034)
4.1.1 Global Burosumab Sales by Type (2024-2024)
4.1.2 Global Burosumab Sales by Type (2024-2034)
4.1.3 Global Burosumab Sales Market Share by Type (2024-2034)
4.2 Global Burosumab Revenue by Type (2024-2034)
4.2.1 Global Burosumab Revenue by Type (2024-2024)
4.2.2 Global Burosumab Revenue by Type (2024-2034)
4.2.3 Global Burosumab Revenue Market Share by Type (2024-2034)
4.3 Global Burosumab Price by Type (2024-2034)
5 Segment by Application
5.1 Global Burosumab Sales by Application (2024-2034)
5.1.1 Global Burosumab Sales by Application (2024-2024)
5.1.2 Global Burosumab Sales by Application (2024-2034)
5.1.3 Global Burosumab Sales Market Share by Application (2024-2034)
5.2 Global Burosumab Revenue by Application (2024-2034)
5.2.1 Global Burosumab Revenue by Application (2024-2024)
5.2.2 Global Burosumab Revenue by Application (2024-2034)
5.2.3 Global Burosumab Revenue Market Share by Application (2024-2034)
5.3 Global Burosumab Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Ultragenyx
6.1.1 Ultragenyx Corporation Information
6.1.2 Ultragenyx Description and Business Overview
6.1.3 Ultragenyx Burosumab Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Ultragenyx Burosumab Product Portfolio
6.1.5 Ultragenyx Recent Developments/Updates
6.2 Kyowa Kirin
6.2.1 Kyowa Kirin Corporation Information
6.2.2 Kyowa Kirin Description and Business Overview
6.2.3 Kyowa Kirin Burosumab Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Kyowa Kirin Burosumab Product Portfolio
6.2.5 Kyowa Kirin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Burosumab Industry Chain Analysis
7.2 Burosumab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Burosumab Production Mode & Process
7.4 Burosumab Sales and Marketing
7.4.1 Burosumab Sales Channels
7.4.2 Burosumab Distributors
7.5 Burosumab Customers
8 Burosumab Market Dynamics
8.1 Burosumab Industry Trends
8.2 Burosumab Market Drivers
8.3 Burosumab Market Challenges
8.4 Burosumab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Burosumab Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Burosumab Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Burosumab Market Competitive Situation by Manufacturers in 2022
Table 4. Global Burosumab Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Burosumab Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Burosumab Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Burosumab Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Burosumab Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Burosumab, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Burosumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Burosumab, Product Type & Application
Table 12. Global Key Manufacturers of Burosumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Burosumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Burosumab as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Burosumab Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Burosumab Sales by Region (2024-2024) & (K Units)
Table 18. Global Burosumab Sales Market Share by Region (2024-2024)
Table 19. Global Burosumab Sales by Region (2024-2034) & (K Units)
Table 20. Global Burosumab Sales Market Share by Region (2024-2034)
Table 21. Global Burosumab Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Burosumab Revenue Market Share by Region (2024-2024)
Table 23. Global Burosumab Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Burosumab Revenue Market Share by Region (2024-2034)
Table 25. North America Burosumab Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Burosumab Sales by Country (2024-2024) & (K Units)
Table 27. North America Burosumab Sales by Country (2024-2034) & (K Units)
Table 28. North America Burosumab Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Burosumab Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Burosumab Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Burosumab Sales by Country (2024-2024) & (K Units)
Table 32. Europe Burosumab Sales by Country (2024-2034) & (K Units)
Table 33. Europe Burosumab Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Burosumab Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Burosumab Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Burosumab Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Burosumab Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Burosumab Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Burosumab Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Burosumab Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Burosumab Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Burosumab Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Burosumab Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Burosumab Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Burosumab Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Burosumab Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Burosumab Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Burosumab Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Burosumab Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Burosumab Sales (K Units) by Type (2024-2024)
Table 51. Global Burosumab Sales (K Units) by Type (2024-2034)
Table 52. Global Burosumab Sales Market Share by Type (2024-2024)
Table 53. Global Burosumab Sales Market Share by Type (2024-2034)
Table 54. Global Burosumab Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Burosumab Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Burosumab Revenue Market Share by Type (2024-2024)
Table 57. Global Burosumab Revenue Market Share by Type (2024-2034)
Table 58. Global Burosumab Price (US$/Unit) by Type (2024-2024)
Table 59. Global Burosumab Price (US$/Unit) by Type (2024-2034)
Table 60. Global Burosumab Sales (K Units) by Application (2024-2024)
Table 61. Global Burosumab Sales (K Units) by Application (2024-2034)
Table 62. Global Burosumab Sales Market Share by Application (2024-2024)
Table 63. Global Burosumab Sales Market Share by Application (2024-2034)
Table 64. Global Burosumab Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Burosumab Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Burosumab Revenue Market Share by Application (2024-2024)
Table 67. Global Burosumab Revenue Market Share by Application (2024-2034)
Table 68. Global Burosumab Price (US$/Unit) by Application (2024-2024)
Table 69. Global Burosumab Price (US$/Unit) by Application (2024-2034)
Table 70. Ultragenyx Corporation Information
Table 71. Ultragenyx Description and Business Overview
Table 72. Ultragenyx Burosumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Ultragenyx Burosumab Product
Table 74. Ultragenyx Recent Developments/Updates
Table 75. Kyowa Kirin Corporation Information
Table 76. Kyowa Kirin Description and Business Overview
Table 77. Kyowa Kirin Burosumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Kyowa Kirin Burosumab Product
Table 79. Kyowa Kirin Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Burosumab Distributors List
Table 83. Burosumab Customers List
Table 84. Burosumab Market Trends
Table 85. Burosumab Market Drivers
Table 86. Burosumab Market Challenges
Table 87. Burosumab Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Burosumab
Figure 2. Global Burosumab Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Burosumab Market Share by Type in 2022 & 2034
Figure 4. 10mg/mL Product Picture
Figure 5. 20mg/mL Product Picture
Figure 6. 30mg/mL Product Picture
Figure 7. Global Burosumab Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Burosumab Market Share by Application in 2022 & 2034
Figure 9. Minor Patients Over 1 Year Old
Figure 10. Adult Patients
Figure 11. Global Burosumab Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 12. Global Burosumab Market Size (2024-2034) & (US$ Million)
Figure 13. Global Burosumab Sales (2024-2034) & (K Units)
Figure 14. Global Burosumab Average Price (US$/Unit) & (2024-2034)
Figure 15. Burosumab Report Years Considered
Figure 16. Burosumab Sales Share by Manufacturers in 2022
Figure 17. Global Burosumab Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Burosumab Players: Market Share by Revenue in 2022
Figure 19. Burosumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 20. Global Burosumab Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 21. North America Burosumab Sales Market Share by Country (2024-2034)
Figure 22. North America Burosumab Revenue Market Share by Country (2024-2034)
Figure 23. United States Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Canada Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Europe Burosumab Sales Market Share by Country (2024-2034)
Figure 26. Europe Burosumab Revenue Market Share by Country (2024-2034)
Figure 27. Germany Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. France Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. U.K. Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Italy Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Russia Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Asia Pacific Burosumab Sales Market Share by Region (2024-2034)
Figure 33. Asia Pacific Burosumab Revenue Market Share by Region (2024-2034)
Figure 34. China Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Japan Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. South Korea Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. India Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Australia Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. China Taiwan Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Southeast Asia Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Latin America Burosumab Sales Market Share by Country (2024-2034)
Figure 42. Latin America Burosumab Revenue Market Share by Country (2024-2034)
Figure 43. Mexico Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Brazil Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Argentina Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Middle East & Africa Burosumab Sales Market Share by Country (2024-2034)
Figure 47. Middle East & Africa Burosumab Revenue Market Share by Country (2024-2034)
Figure 48. Turkey Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Saudi Arabia Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. UAE Burosumab Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Global Sales Market Share of Burosumab by Type (2024-2034)
Figure 52. Global Revenue Market Share of Burosumab by Type (2024-2034)
Figure 53. Global Burosumab Price (US$/Unit) by Type (2024-2034)
Figure 54. Global Sales Market Share of Burosumab by Application (2024-2034)
Figure 55. Global Revenue Market Share of Burosumab by Application (2024-2034)
Figure 56. Global Burosumab Price (US$/Unit) by Application (2024-2034)
Figure 57. Burosumab Value Chain
Figure 58. Burosumab Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed